Literature DB >> 28281959

miR-489 Suppresses Proliferation and Invasion of Human Bladder Cancer Cells.

Jing Li1, Weixing Qu, Yazhou Jiang, Yi Sun, Yongyi Cheng, Tiejun Zou, Shuangkuan Du.   

Abstract

MicroRNAs (miRNAs) have been shown to be involved in bladder cancer progression. miR-489 (also known as miR-489-3p) was recently reported to be a tumor suppressor in several cancers. However, its exact role and mechanism in the progression of bladder cancer are largely unknown. In this study, we explore the role of miR-489 in the proliferation and invasion of human bladder cancer cells. The miR-489 expression levels were detected in bladder cancer and normal adjacent tissues, as well as in human normal bladder epithelial cells and bladder cancer cell lines. The results showed that miR-489 was sharply reduced in bladder cancer tissues and cell lines. Then the miR-489 mimic or oligo anta-miR-489 was transfected into T24 and UMUC3 bladder cancer cell lines. The results showed that the miR-489 mimic greatly increased the miR-489 level and significantly decreased the proliferation and invasion of T24 and UMUC3 cells. In contrast, the anta-miR-489 had a completely opposite effect on miR-489 expression, cell proliferation, and cell invasion. Moreover, bioinformatics and luciferase reporter gene assays confirmed that miR-489 targeted the mRNA 3'-untranslated region (3'-UTR) region of Jagged1 (JAG1), a Notch ligand. In conclusion, miR-489 suppressed proliferation and invasion of human bladder cancer cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28281959     DOI: 10.3727/096504016X14666990347518

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  16 in total

1.  miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis.

Authors:  Han Wu; Xiuhong Wang; Tingting Wu; Su Yang
Journal:  Genes Genomics       Date:  2019-12-23       Impact factor: 1.839

2.  Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.

Authors:  Mithil Soni; Yogin Patel; Eleni Markoutsa; Chunfa Jie; Shou Liu; Peisheng Xu; Hexin Chen
Journal:  Mol Cancer Res       Date:  2018-05-21       Impact factor: 5.852

3.  MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.

Authors:  Juanjuan Li; Shouquan Dong; Mingliang Ye; Ganjing Peng; Jie Luo; Chun Wang; Jing Wang; Qiu Zhao; Ying Chang; Hongling Wang
Journal:  Dig Dis Sci       Date:  2020-03-07       Impact factor: 3.199

4.  miR-489-3p inhibits TLR4/NF-κB signaling to prevent inflammation in psoriasis.

Authors:  Yujian Ye; Ping Wang; Fangmei Zhou
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

5.  Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis.

Authors:  Zihao Wang; Lu Gao; Xiaopeng Guo; Chenzhe Feng; Kan Deng; Wei Lian; Bing Xing
Journal:  Oncol Rep       Date:  2019-05-28       Impact factor: 3.906

6.  Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2.

Authors:  Lu Chen; Le Chen; Zhiyuan Qin; Jinxiu Lei; Sheng Ye; Kui Zeng; Hua Wang; Meidan Ying; Jianqing Gao; Su Zeng; Lushan Yu
Journal:  Acta Pharm Sin B       Date:  2019-01-08       Impact factor: 11.413

7.  miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1.

Authors:  Peide Bai; Wei Li; Zhenghua Wan; Yujuan Xiao; Wen Xiao; Xuegang Wang; Zhun Wu; Kaiyan Zhang; Yongfeng Wang; Bin Chen; Jinchun Xing; Tao Wang
Journal:  Cancer Manag Res       Date:  2020-04-23       Impact factor: 3.989

8.  Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer.

Authors:  Shun-Hong Mao; Chun-Hua Zhu; Yu Nie; Jian Yu; Lei Wang
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

9.  Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP.

Authors:  Xuedong Wang; Xinguo Wang; Juan Gu; Ming Zhou; Zhimin He; Xinhui Wang; Soldano Ferrone
Journal:  Oncotarget       Date:  2017-12-06

10.  Metformin Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma through Circ_0003214-Mediated MiR-489-3p-ADAM10 Pathway.

Authors:  Xiaoqiang Chen; Chen Li; Wei Chen; Shuchun Lin; Xuehan Yi; Qin Lin; Hao Xu; Desheng Wang
Journal:  J Oncol       Date:  2021-07-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.